NINETY per cent of Alzheimer’s cases are linked to the same gene, scientists have discovered. About 750,000 people in the UK ...

Researchers have added to a stack of existing evidence that 40 Hz gamma frequencies could help to treat Alzheimer's disease.

Sharon Runge has become the first patient in Canadian history to receive an infusion of an Alzheimer’s drug recently approved ...

New research shows that aging blood can accelerate Alzheimer’s-like changes in the brain, while younger blood may offer ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...

Chinese scientists have demonstrated that simple, non-invasive sound therapy can produce significant and remarkably long-lasting biological changes in aged monkeys, offering new hope for a potential ...

Discovery could redirect drug development for disease affecting 6.7 million Americans The two AMPKα isoforms can have ...

Donald Trump has faced renewed scrutiny regarding his mental health after an unusual interaction during a White House meeting ...

Managed care organizations should evolve cost models to capture savings from dextromethorphan-bupropion’s safety profile, which avoids costly complications associated with traditional Alzheimer ...

"Neumora’s Alzheimer’s disease agitation drug shows early success in Phase Ib trial" was originally created and published by ...

FDA grants Priority Review to AXS-05 (dextromethorphan/bupropion) for the treatment of agitation associated with Alzheimer disease.

A study by UVM researchers published last month points to what the authors say is a possible way of treating Alzheimer's and ...